Genesis HealthCare (GEN) Misses Q2 EPS by 27c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Genesis Healthcare Reports Second Quarter 2016 Results
August 4, 2016 4:35 PM EDTKENNETT SQUARE, Pa., Aug. 4, 2016 /PRNewswire/ --Â Genesis HealthCare (Genesis, or the Company) (NYSE: GEN), one of the largest post-acute care providers in the United States, today announced operating results for the second quarter ended June 30, 2016.Â
Summary of Recent Financing ActivityÂ
Addresses near-term refinancing and liquidity risks by entering into a new $120 million four-year term loan agreement on July 29, 2016 and paying off the prior term loan that would have matured in December 2017; Obtains greater flexibility to operate and grow by establishing covenants with significant credit... More